Peptide Library

GLP-1 agonists and related compounds for metabolic weight loss. Retatrutide leads with 28.7% average weight loss as a triple-agonist (full Philippines 2026 sourcing guide), followed by the dual-agonist tirzepatide at 22.5% (Mounjaro vs research-grade in the Philippines), and the proven semaglutide at 15% (Ozempic sourcing guide). For a full comparison, visit the weight loss hub.

Tissue repair, wound healing, and anti-inflammatory peptides. BPC-157 is the most popular for injury recovery, often stacked with TB-500 for systemic healing. KPV targets gut inflammation specifically.

Collagen synthesis, skin rejuvenation, and anti-wrinkle peptides. GHK-Cu is known as the "glow peptide" for its dramatic effects on skin quality. SNAP-8 provides topical anti-wrinkle effects, while Epitalon targets cellular aging through telomerase activation.

GH secretagogues and GHRH analogues for body composition, recovery, and anti-aging. The Ipamorelin + CJC-1295 stack is the gold standard. Tesamorelin is FDA-approved for visceral fat reduction.

Mitochondrial optimizers and longevity-focused peptides. NAD+ supports cellular energy metabolism (see IV drip clinics and home protocols in the Philippines), MOTS-c is an exercise mimetic, and SS-31 provides mitochondrial-targeted cardioprotection.

Nootropics and mood-regulating peptides. Semax is the stimulating nootropic that dramatically increases BDNF, while Selank provides anxiety relief without sedation. DSIP targets deep sleep quality.

Melanocortin peptides for tanning and libido. Melanotan I provides gradual tanning without the sexual side effects of Melanotan II, which produces faster tanning with libido effects.

Hormone-regulating peptides for fertility and testosterone. Kisspeptin naturally stimulates testosterone and luteinizing hormone production without suppressing the HPG axis.

• P-01

  CJC/Ipamorelin Protocol

  Gold-standard GH stack

• P-02

  Glow Protocol

  GHK-Cu + BPC-157 + TB-500 for skin

• P-03

  Healing Stack

  BPC-157 + TB-500 for injuries

None of the 32compounds in this library are registered with FDA Philippines as standalone peptide drugs, with the partial exception of recombinant somatropin (Genotropin, Norditropin) for diagnosed pediatric and adult GH deficiency, tesamorelin for HIV-associated lipodystrophy, and the GLP-1 class — Ozempic, Wegovy, Mounjaro — which are licensed and prescribable through endocrinology clinics at Makati Medical Center, St. Luke's BGC, The Medical City, and Manila Doctors Hospital. Everything else lives in research-grade lyophilized-powder territory, sourced through compounding routes or personal import.

Mercury Drug and Watsons stock the syringes and the FDA-registered pharmaceuticals (insulin syringes, BAC water in some branches, Ozempic, Mounjaro by prescription); they do not stock research-grade peptides and will not. The compounding pharmacies clustered around Makati and BGC handle the BAC water, the syringes, and the doctor-requested oral compounds, but the peptide powder itself is almost always a personal-import problem. Bureau of Customs treats single-vial research peptides as personal-use research chemicals at low value — single-parcel volumes through Singapore or Hong Kong forwarders typically clear without intervention. Bulk parcels (10+ vials) and anything declared as "pharmaceutical" draw scrutiny and risk cold-chain breach during clearance, which Manila summer heat makes a real operational problem.

The bloodwork ecosystem here is genuinely good. Hi-Precision and the Makati Med outpatient labs run full hormone panels, IGF-1, HbA1c, fasted insulin, lipid panels, and DEXA body composition for prices that would shock a US user. Most of the protocols in the 32-peptide library benefit from an upfront panel and a 6–8 week retest — the labs make that easy in a way the supply chain doesn't. For where to source the compounds themselves, see the supply index; for COA reasoning, see why COA matters; for legal context, see peptides legal status in the Philippines.

I landed at NAIA in late October 2025 from Austin and started building this library out of my own running protocol. The order I touched compounds matters because the order tracks risk: tirzepatide first (FDA PH-registered as Mounjaro, 5mg vials at the Glorietta 4 Mercury Drug for USD 290 / box of four), then GHK-Cu and BPC-157 (research-grade, sourced through a personal-import route in early January 2026), then the more speculative compounds — TB-500, MOTS-c, kisspeptin — only after I had a working baseline panel from Hi-Precision Diagnostics in Bonifacio Global City. Every protocol on this site comes with a Hi-Precision panel attached because that is how I run it on myself: USD 95 to USD 150 for a full panel, results in 48 hours, retest at week 6 to 8.

My twelve-week glow run (January 8 to April 2, 2026) used GHK-Cu 3mg subQ daily plus BPC-157 250mcg daily plus a 0.8% topical from a Salcedo Village compounder for USD 38 per 30mL bottle. Photos were taken in the same BGC condo bathroom, same overhead lighting, every Sunday morning. The eleven-week tirzepatide run from late October 2025 dropped me from 92.4 kg to 84.1 kg at 5mg weekly, then I plateaued in February 2026 — see the plateau FAQfor the full Hi-Precision workup that pulled me out of it. Every compound profile in this library is written by someone running it or someone I trust who is running it. If a peptide is in here without a personal log attached, it's because the safety data is solid enough that the protocol works without me having personally cycled it (Ozempic, Wegovy, somatropin).

With the exception of FDA Philippines-registered products (Ozempic, Wegovy, Mounjaro, Tesamorelin, recombinant somatropin), every compound in this library is sold and used as a research-grade chemical. That means: no human-grade GMP facility, no FDA Philippines registration, variable purity, no guarantee the label dose matches the actual dose, and limited human safety data — particularly for BPC-157, TB-500, GHK-Cu, MOTS-c, kisspeptin, Epitalon, DSIP, KPV, and the Melanotan series. Multiple compounds (BPC-157, TB-500, GHK-Cu, kisspeptin) are on the World Anti-Doping Agency's prohibited list, which has implications for any user subject to drug testing.

Nothing on this site is medical advice. The library exists because someone who is going to use these compounds anyway should at least have decent dosing logic, sourcing logic, and a panel-driven workup — and because the alternative for a Filipino-American living in Manila is Reddit threads and supplier-marketing copy, both of which are worse. If you have a serious underlying condition (cardiovascular disease, a personal or family history of medullary thyroid carcinoma, MEN-2 syndrome, active malignancy, pregnancy, or unmanaged psychiatric illness), the right move is an endocrinology consult at Makati Medical Center or St. Luke's BGC before you order a single vial. USD 60 to 100 cash, bookable within a week. Use it.

• S-01Trial
  Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)

  Jastreboff AM, Aronne LJ, Ahmad NN, et al. · New England Journal of Medicine 387(3):205-216 · 2022

• S-02Trial
  Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial

  Jastreboff AM, Kaplan LM, Frias JP, et al. · New England Journal of Medicine 389(6):514-526 · 2023

• S-03Trial
  Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1)

  Wilding JPH, Batterham RL, Calanna S, et al. · New England Journal of Medicine 384(11):989-1002 · 2021

• S-04Mechanism
  Pentadecapeptide BPC 157 and the central nervous system

  Sikiric P, Hahm KB, Blagaic AB, et al. · Inflammopharmacology 26(2):343-365 · 2018

• S-05Mechanism
  GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

  Pickart L, Vasquez-Soltero JM, Margolina A · BioMed Research International 2015:648108 · 2015

• S-06Reference
  FDA Philippines — Verification Portal for Registered Drug Products

  Food and Drug Administration of the Philippines · verification.fda.gov.ph · 2026

• S-07Reference
  Bureau of Customs Philippines — Personal Effects and Balikbayan Box Guidelines

  Bureau of Customs of the Philippines · customs.gov.ph · 2026

• S-08Guideline
  World Anti-Doping Agency — Prohibited List 2026

  World Anti-Doping Agency · wada-ama.org · 2026